Microdosing a GLP-1 has incredible benefits for maintaining a healthy weight and combatting inflammation
However, 25% of the study participants were followed for 6.1 years or longer and the cumulative incidence curves showed no signs of an emerging risk increase with up to 10 years of follow-up
Gout There are some limited studies in patients with gout, some reporting a possible flare of gout when therapy with GLP1 is started, mostly due to rapid weight loss and dehydration that may precipitate gout attacks
It is not a medicine, food, supplement, cosmetic, or medical device, and is not for human or veterinary use, administration, or consumption
GLP-1RAs have been insufficiently evaluated as treatments for NUD